Inflammation and malnutrition as markers of poor outcomes in head and neck cancer patients treated with nivolumab-Reference-Cited by-同舟云学术

Inflammation and malnutrition as markers of poor outcomes in head and neck cancer patients treated with nivolumab

Published:2023-08-03 Issue:8 Volume:143 Page:714-720
ISSN:0001-6489
Container-title:Acta Oto-Laryngologica
language:en
Short-container-title:Acta Oto-Laryngologica

Author:

Arihara Yohei¹,Takada Kohichi¹,Murase Kazuyuki¹,Kawamura Kentaro¹,Kakiuchi Akito²^ORCID,Kurose Makoto²,Sasaki Takanori³,Ogi Kazuhiro³,Yamazaki Masahide⁴,Miyazaki Akihiro³,Kato Junji¹,Takano Kenichi²

Affiliation:

1. Department of Medical Oncology, Sapporo Medical University, Sapporo, Japan

2. Department of Otolaryngology - Head and Neck Surgery, Sapporo Medical University, Sapporo, Japan

3. Department of Oral Surgery, Sapporo Medical University, Sapporo, Japan

4. Department of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan

Funder

JSPS KAKENHI Grant-in-Aid for Young Scientists

Publisher

Informa UK Limited

Subject

Otorhinolaryngology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00016489.2023.2240372

Reference20 articles.

1. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

2. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

3. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

4. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

5. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to: Unlocking the potential of the geriatric nutritional risk indicator in predicting outcomes of neoadjuvant immunotherapy for esophageal cancer;European Journal of Surgical Oncology;2024-09

2. Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis;Cancers;2024-05-11

3. Delineation of the “Oropharyngeal Mucosa” and Limiting its Dose in Head and Neck Cancer Patients Spares the Oropharynx Without Compromising Target Coverage;Cancer Control;2024-01

4. Nivolumab;Reactions Weekly;2023-12-09

5. Efficacy of the Geriatric Nutritional Risk Index for Predicting Overall Survival in Patients with Head and Neck Cancer: A Meta-Analysis;Nutrients;2023-10-12